Protalix BioTherapeutics (PLX) Work In Process (2012 - 2026)
Protalix BioTherapeutics' Work In Process came in at $8.25 million for Q2 2026, up 1.4% from $8.14 million a year earlier but down 9.1% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Work In Process (2012 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics' Work In Process was $9.38 million, down 16.6% from FY2024.
- Work In Process carries a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
- Going back by year, Work In Process was $11.25 million in FY2024 (+24.2%), $9.06 million in FY2023 (+238.1%), $2.68 million in FY2022 (-17.9%) and $3.26 million in FY2021 (+13.0%).
- The five-year range for quarterly Work In Process is $1.53 million (Q1 2023) to $12.25 million (Q3 2024).
- Year-over-year, Work In Process increased in four of the last eight quarters, with an average decline of 4.7%.
- The fastest year-over-year change in Work In Process over five years came in Q1 2024 (growth of 498.1%), and the weakest in Q3 2025 (a decline of 56.3%).
- Business Quant data shows PLX's Work In Process at $9.08 million (Q1 2026), $9.38 million (Q4 2025) and $5.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.13 Bn | 1,102.72 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.88 Bn | 261.87 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.36 Bn | 235.05 Bn | 12.86 Bn |
| 7 | Amgen | 235.80 Bn | 191.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.97 Bn | 6.22 Bn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn |
| 10 | Protalix BioTherapeutics | 203.57 Mn | 52.18 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.25 Mn |
| Mar 31, 2026 | 9.08 Mn |
| Dec 31, 2025 | 9.38 Mn |
| Sep 30, 2025 | 5.36 Mn |
| Jun 30, 2025 | 8.14 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 11.25 Mn |
| Sep 30, 2024 | 12.25 Mn |
| Jun 30, 2024 | 10.87 Mn |
| Mar 31, 2024 | 9.17 Mn |
| Dec 31, 2023 | 9.06 Mn |
| Sep 30, 2023 | 9.12 Mn |
| Jun 30, 2023 | 3.32 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 2.68 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 3.37 Mn |
| Dec 31, 2021 | 3.26 Mn |
| Sep 30, 2021 | 3.51 Mn |
API Access
Protalix BioTherapeutics Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();